Prediction of Crossmatch Outcome of Highly Sensitized Patients by Single and/or Multiple Antigen Bead Luminex Assay
Authors:
- Smita VaidyaSVSmita Vaidya
- David PartlowDPDavid Partlow
- Brian SusskindBSBrian Susskind
- Maryam NoorMNMaryam Noor
- Titus BarnesTBTitus Barnes
- Kristine GugliuzzaKGKristine Gugliuzza
- 15 December 2006
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 82 (11) , 1524-1528
Abstract
We used a solid-phase assay to identify human leukocyte antigen (HLA) Class I and II specificities in highly reactive sera, and applied this information to predict crossmatch outcome with greater than 90% accuracy. Sera from 20 highly sensitized end-stage renal disease patients reactive to 70-100% of HLA Class I and II antigen panel were analyzed by single and/or multiple antigen flow microparticle bead assay using Luminex platform (Luminex assay). These sera contained antibodies directed against high frequency public HLA class I and/or II epitopes accounting for 70-100% of serum's total reactivity. More than 2,000 complement dependent cytotoxicity (CDC) and 200 flow crossmatches (FLXM) were performed using sera from these patients and deceased donor T and B lymphocytes. Luminex serum analysis was able to correctly predict outcomes of 95% of T and B cell FLXM. In contrast, predictive values for the CDC T and B cell crossmatches by Luminex serum analysis were only 77% and 75%, respectively. The use of serum analysis in donor selection would have reduced the total number of required FLXM by more than 50%. The frequency of negative T cell FLXM was 56% when donors were selected randomly; however, if serum antibody analysis had been used to preselect the donors by excluding donors that were likely to be positive, the frequency of corresponding negative crossmatches would have increased up to 93%. This approach to donor selection may allow wider geographic sharing of cadaver donor organs without actually performing the crossmatch.Keywords
This publication has 25 references indexed in Scilit:
- Preformed Cytotoxic Antibodies in Potential Allograft Recipients: Recent DataHuman Immunology, 2005
- Humoral Theory of Transplantation: Mechanism, Prevention, and TreatmentHuman Immunology, 2005
- Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantationTransplantation, 2004
- Relative AHLA-DRB1*04 allele frequencies in five United States populations found in a hematopoietic stem cell volunteer donor registry and seven new DRB1*04 allelesHuman Immunology, 2002
- DRB1∗03 diversity and DRB3 associations in five major population groups in the United StatesHuman Immunology, 2002
- IMPROVED FLOW CYTOMETRIC DETECTION OF HLA ALLOANTIBODIES USING PRONASETransplantation, 2001
- PREIDCTION OF CROSSMATCH OUTCOME IN HIGHLY SENSITIZED DIALYSIS PATIENTS BASED ON THE IDENTIFICATION OF SERUM HLA ANTIBODIESTransplantation, 1986
- HLA serological cross-reactivity: HLA-B15 has two public antigensHuman Immunology, 1980
- A public antigenic determinant in the HLA-B5 cross-reacting group— A basis for cross-reactivity and a possible link with Behcet's diseaseHuman Immunology, 1980
- Public antigenic determinant on a family of HLA-B molecules.Journal of Clinical Investigation, 1979